Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

New Haven, Connecticut 06511


Purpose:

This drug-drug interaction study is being conducted to evaluate the potential effect of Dimebon on the pharmacokinetics on dextromethorphan, a probe substrate of the cytochrome P450 2D6 (CYP2D6) enzyme, after multiple dose administration to healthy adult subjects.


Criteria:

Inclusion Criteria: - Healthy adult subjects. - Extensive or ultra-rapid metabolizers of CYP2D6 substrates, predicted by genotype. Exclusion Criteria: - Existence of significant medical conditions that would impact study results or pose unacceptable risks to study subjects. - Pregnant or nursing females or females of childbearing potential who are unwilling or unable to use an acceptable method of contraception. - Use of prescription or nonprescription drugs and dietary supplements within 7 days prior to the first dose of study medication.


NCT ID:

NCT00788047


Primary Contact:

Study Director
Pfizer CT.gov Call Center
Pfizer


Backup Contact:

N/A


Location Contact:

New Haven, Connecticut 06511
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: October 09, 2019

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.